What do the numbers say about Veedol Corportion (VEEDOL)? Here's a look at its financials, valuation, and ownership data.
Veedol Revenue Trend
A 1.8% jump in revenue took Veedol Corportion's top line to ₹1,989 Cr in FY2025.
A 6.7% CAGR over 10 years is middle-of-the-road. Veedol Corportion's top line moved from ₹1,037 Cr to ₹1,989 Cr in that period.
In terms of scale, Veedol Corportion's ₹1,989 Cr in annual revenue positions it as a mid-sized chemicals - speciality company.
Looking at the year-on-year numbers, Veedol Corportion has seen 4 years of unbroken revenue growth.
| Year | Revenue | YoY % |
|---|---|---|
| FY2025 | ₹1,989 Cr | +1.8% |
| FY2024 | ₹1,953 Cr | +4.5% |
| FY2023 | ₹1,869 Cr | +20.2% |
| FY2022 | ₹1,555 Cr | +23.6% |
| FY2021 | ₹1,258 Cr | — |
View Veedol Corportion's full 10-year revenue trend with CAGR analysis →
Veedol Profitability
Bottom-line growth was evident, with Veedol Corportion posting ₹169 Cr in net profit for FY2025 — up 17.4% from ₹144 Cr.
The company squeezed out better margins in FY2025, with net margin at 8.5% versus 7.4% in FY2024.
On an EPS basis, the company earned ₹99.29 (diluted) in FY2025 versus ₹84.10 in FY2024.
Is Veedol Undervalued
The P/E Ratio valuation pegs Veedol Corportion's fair value at ₹1,679, which is 18.7% upside from the current price.
Veedol Corportion shares are currently trading at ₹1,413.80.
Craytheon also calculates intrinsic value using the EPS Growth model. The full breakdown with assumptions is available in the detailed analysis.
| Model | Est. Fair Value | vs. Current Price |
|---|---|---|
| P/E Ratio | ₹1,679 | 18.7% upside to fair value |
| EPS Growth | Upgrade | Upgrade |
See all valuation models for Veedol Corportion with detailed assumptions →
Veedol Shareholding Pattern
The promoter stake rose to 64.6% from 62.4% over the past 4 quarters.
As of March 2026, FIIs own 1.1% of the company — down from 1.1% a year earlier.
No movement from DIIs — their 1.2% holding is unchanged year-over-year.
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Mar 2026 | 64.6% | 1.1% | 1.2% | 30.7% |
| Dec 2025 | 64.6% | 1.2% | 1.2% | 30.6% |
| Sep 2025 | 64.6% | 1.4% | 1.2% | 30.4% |
| Jun 2025 | 62.4% | 1.1% | 1.2% | 32.9% |
Track quarterly shareholding changes for Veedol Corportion →
Veedol Balance Sheet
Proportional view as of 3 Jun 2026. Hover blocks for details.
Assets
Liabilities & Equity
In FY2025, the total asset base came in at ₹12.53B, up 8.4% YoY from ₹11.56B.
Inventories accounts for 26.6% of the total, ahead of Receivables (23.2%) and Property, Plant & Equipment (15.4%).
Capital structure: 73.0% equity, 1.8% debt, 25.3% operating liabilities. Over the year, debt is up 1,656.8% and equity is up 10.5%.
Balance sheet composition — FY 2025
| Category | Value |
|---|---|
| Cash & ST Investments | 445.40M |
| Receivables | 2.90B |
| Inventories | 3.33B |
| Property, Plant & Equipment | 1.92B |
| Investments | 781.50M |
| Intangibles & Goodwill | 1.29B |
| Other Assets | 1.85B |
| Category | Value |
|---|---|
| Equity | 9.14B |
| Short-term Debt | 77.80M |
| Long-term Debt | 141.80M |
| Trade Payables | 1.66B |
| Other Liabilities | 1.51B |
What Stands Out About Veedol
What should investors take away from Veedol Corportion's (VEEDOL) latest numbers? Here's the summary.
Revenue of ₹1,989 Cr in FY2025, up 1.8% year-over-year.
Long-term revenue has been compounding at 6.7% annually over 10 years.
The company is profitable, with a net margin of 8.5% and net income of ₹169 Cr.
The P/E Ratio model implies 18.7% upside to fair value from the current price. The remaining two models are worth cross-checking before drawing a conclusion — sign up to see the full analysis.
Unlock Full Analysis
Craytheon's full analysis of Veedol Corportion goes deeper: three valuation models, growth metrics, and 10 years of financial data.